Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2020-08-07 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
[기재정정]타법인주식및출자증권처분결정
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from the Korean DART system regarding the 'Disposal of Shares and Investment Securities of Other Corporations' (타법인주식및출자증권처분결정). It is a correction report (정정신고) detailing changes to the payment schedule for a previously announced asset disposal. Since this is a specific regulatory disclosure regarding corporate asset transactions and does not fit into the other specialized categories like M&A (which usually refers to company-level takeovers) or share buybacks, it is best classified as a general regulatory filing.
2020-08-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual relationships (such as collateral agreements) of major shareholders and their special related parties. This corresponds to the 'Major Shareholding Notification' category.
2020-07-21 Korean
[기재정정]타법인주식및출자증권처분결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Well Biotech) regarding the 'Decision to Dispose of Shares and Investment Securities of Other Corporations'. It details the amendment of a previous disclosure (dated 2019-02-12) specifically regarding the payment schedule for the disposal of shares in Biogenic Korea. This type of corporate disclosure regarding asset disposal, M&A-related divestment, or significant changes in investment holdings is classified under 'Regulatory Filings' (RNS) as it serves as a formal public announcement of a corporate action that does not fit into more specific categories like M&A (which usually implies a takeover bid) or Share Issue (which is for capital raising).
2020-07-15 Korean
[기재정정]타법인주식및출자증권처분결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Well Biotech) regarding the 'Decision to Dispose of Shares and Securities of Other Corporations'. It details a correction to a previous filing (amendment) concerning the payment schedule for the disposal of shares in 'Biogenic Korea'. This type of corporate action, involving the sale of assets or equity in other entities, is classified as a general regulatory announcement under the RNS category as it does not fit into specific categories like M&A (which usually refers to company-level takeovers) or share buybacks (which refers to own shares).
2020-06-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-06-10 Korean
[기재정정]타법인주식및출자증권처분결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Well Biotech) regarding the 'Disposal of shares and securities of other corporations' (타법인주식및출자증권처분결정). It details a correction (정정신고) to a previous filing concerning the timeline of a share disposal transaction. Since this is a specific corporate action announcement regarding the sale of assets/shares that does not fit into the other specialized categories like M&A (which usually implies a merger or takeover) or Share Issue (which is for the company's own capital), it falls under the general regulatory filing category.
2020-05-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.